BRIEF—Endo names Blaise Coleman as president and CEO

Ireland-incorporated Endo International yesterday announced that Blaise Coleman, who has served as the company's executive vice president and chief financial officer since 2016, will succeed Paul Campanelli as president and chief executive and will become a member of the board of directors effective March 6, 2020.

Mr Campanelli will continue to serve as chairman of the board.

This appointment will complete the CEO succession plan that Endo announced in November 2019.

Mr Coleman has more than 20 years of pharmaceutical industry experience.

Prior to joining Endo in 2015, he held a number of leadership roles of increasing responsibility with AstraZeneca and Johnson & Johnson.